SEARCH

SEARCH BY CITATION

References

  • 1
    Prieto J, Yuste JR, Beloqui O, Civeira MP, Riezu JI, Aguirre B, Sangro B. Anticardiolipin antibodies in chronic hepatitis C. Implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology 1996; 23: 199204.
  • 2
    Gotoh M, Matsuda J. Human immunodeficiency virus rather than hepatitis C virus infection is relevant to the development of an anti-cardiolipin antibody. Am J Hematol 1995; 50: 220222.
  • 3
    Colaco CB, Mackie IJ, Irving W, Machin SJ. Anti-cardiolipin antibodies in viral infection. Lancet 1989; 334: 622.
  • 4
    Goodnight SH. Antiphospholipid antibodies and thrombosis. Curr Opin Hematol 1994; 1: 354361.
  • 5
    Mehdi H, Kaplan MJ, Anlar FY, Yang X, Bayer R, Sutherland K, Peeples ME. Hepatitis B virus surface antigen binds to apolipoprotein H. J Virol 1994; 68: 24152424.
  • 6
    Neurath AR, Strick N. The putative cell receptors for hepatitis B virus (HBV), annexin V and apolipoprotein H bind to lipid components of HBV. Virology 1994; 204: 475477.
  • 7
    Jones JV, James H, Mansour M, Eastwood BJ. B2-glycoprotein I is a cofactor for antibodies reacting with 5 anionic phospholipids. J Rheumatol 1995; 22: 2009.
  • 8
    Cheng HM. Immunophysiology of Antiphospholipid Antibodies. Molecular Biology Intelligence Unit. San Antonio; R. G. Landes Biomedical Publishers, 1994.
  • 9
    Acha-Orbea H. Bacterial and viral superantigens-roles in autoimmunity? Ann Rheum Dis 1993; 52: S6S16.
  • 10
    Shoenfeld Y. Idiotypic induction of autoimmunity–a new aspect of the idiotypic network. FASEB J 1994; 8: 12961301.